Our reports provide an independent, expert view supported by robust and innovative data interrogation and analysis.

Sort by:
Frontier Pharma: Breast Cancer – First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer

Published: Jul-2018

Breast cancer remains a major global healthcare concern despite exceptional levels of public awareness about the disease......

$6995
More Info
Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 – Growth Driven by ongoing Transition from Anti-resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness

Published: Jul-2018

Osteoporosis is a “silent epidemic” and as per the WHO declarations, it is a priority health issue. Osteoporosis.....

$4995
More Info
Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline

Published: Jul-2018

Cancer immunotherapy, which can predominantly be classed as a form of targeted therapy, drives an immune response against.....

$4995
More Info
PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream Targets

Published: Jul-2018

GBI Research’s latest report, PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape,.....

$2995
More Info
Psoriasis Therapeutics in Asia-Pacific Markets to 2024: Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market

Published: Jun-2018

Psoriasis is a common, chronic inflammatory skin condition affecting around 2–3% of the world’s population......

$4995
More Info
Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018

Published: Jun-2018

This report provides an overview of the pipeline landscape for diabetes and associated metabolic conditions. It provides.....

$3995
More Info
Menopausal Disorders Drug Development Pipeline Review, 2018

Published: Jun-2018

This report provides an overview of the pipeline landscape for menopausal disorders. It provides comprehensive information.....

$3995
More Info
Hepatitis Drug Development Pipeline Review, 2018

Published: Jun-2018

This report provides an overview of the pipeline landscape for hepatitis infections. It provides comprehensive information.....

$3995
More Info
Frontier Pharma: Schizophrenia - Diverse First-in-Class Pipeline Shows Promise for Treatment of Negative and Cognitive Symptoms

Published: May-2018

Schizophrenia is a chronic mental disorder that affects 1% of the population – equivalent to 51 million people worldwide.....

$6995
More Info
Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence

Published: May-2018

Breast cancer is the second most common cancer in the world overall, and the most common cancer in women. When diagnosed.....

$4995
More Info
Sort by: